Skip to content

Treatment of knee Osteoarthritis with blood derivate

Treatment of knee Osteoarthritis with Platelet-rich Plasma: prospective and randomized study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-2zh964c
Enrollment
Unknown
Registered
2025-04-09
Start date
2024-09-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other primary knee osteoarthritis

Interventions

The present study is a prospective and randomized clinical trial with the objective of evaluating the effects of using platelet-rich plasma in comparison with hyaluronic acid for the conservative trea

Sponsors

Faculdade de Medicina da Universidade Federal Fluminense
Lead Sponsor
Hospital Universitário Antonio Pedro/Empresa Brasileira de Serviços Hospitalares
Collaborator

Eligibility

Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age between 40 and 70 years old; both sexes; diagnosis of Bilateral Osteoarthritis of the knee, according to the criteria of the American College of Rheumatology; radiographs with a Kellgren-Lawrence classification of less than III in both knees; present full range of motion (0 to 120°)

Exclusion criteria

Exclusion criteria: History of previous trauma, infection or surgery in the same knee in the last 2 years;limb malalignment (varus>10º and valgus > 15º);corticosteroid infiltration in the same knee in the last 3 months;hyaluronic acid ; unfiltration in the same knee in the last 12 months;inflammatory, autoimmune or neoplasic disease;body mass index> 35 kg/m2; use of immunosuppressants or anticoagulants; active neoplasia; hematologic disorders; history of transmissible disease accute or chronic; living outside Rio de Janeiro metropolitan area; participants without full autonomy, blind, deaf or illiterate

Design outcomes

Primary

MeasureTime frame
Pain analysed by visual analog scale

Secondary

MeasureTime frame
Function analysed by WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) and KSS (Knee Society Score)

Countries

Brazil

Contacts

Public ContactEduardo de Sousa

Universidade Federal Fluminense

eduardobranco@id.uff.br+55-21-972388005

Outcome results

None listed

Source: REBEC (via WHO ICTRP)